ANTHONY GREGG LAPOINTE
CIK 1331860 · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$702.6K
Companies
11
Total Filings
60
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RIGL | Director | 18,250 | $38.50 | $702.6K | $0 | 10 | 2026-05-19 |
| Astria Therapeutics, Inc. (ATXS) Delisted | Director | — | $12.58 | — | $0 | 6 | 2026-01-23 |
| SNGX | Director | — | $0.36 | — | $0 | 4 | 2025-06-20 |
| SOLIGENIX, INC. (SNGXW) Delisted | Director | — | $0.01 | — | $0 | 5 | 2021-09-24 |
| Astria Therapeutics, Inc. (CATB) Delisted | Director | — | $8.54 | — | $0 | 5 | 2021-06-02 |
| SCICLONE PHARMACEUTICALS INC (SCLN) Delisted | Director | — | — | — | $0 | 10 | 2017-10-16 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Director | — | — | — | $0 | 1 | 2017-05-24 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Director | 0 | — | — | $0 | 4 | 2016-10-26 |
| ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Director | — | — | — | $0 | 2 | 2016-06-21 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | — | — | — | $0 | 2 | 2010-01-04 |
| QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | Director | — | — | — | $0 | 1 | 2007-01-04 |
Recent Filings · Page 2 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-06 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-21 | SNGX | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-23 | RIGL | Grant (A) | +25,000 | $0 | EDGAR |
| 2021-09-24 | SOLIGENIX, INC. (SNGXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-02 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-21 | RIGL | Grant (A) | +25,000 | $0 | EDGAR |
| 2020-09-18 | SOLIGENIX, INC. (SNGXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-12 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.